Description
Rifamycin SV sodium is used to inhibit susceptible Gram-positive bacteria and to study transcriptional inhibition and rifamycin resistance mechanisms.
Rifamycin SV is a member of the rifamycin family of antibiotics and serves as a core structural compound from which other rifamycin derivatives are developed. The sodium salt form improves aqueous solubility compared to the parent compound, supporting more consistent preparation of antibiotic-supplemented media.
Mechanism: Rifamycin SV binds to the beta subunit of bacterial DNA-dependent RNA polymerase, blocking the initiation of RNA transcription. By preventing RNA chain elongation at an early stage, it suppresses gene expression and inhibits growth in susceptible bacteria. This transcription-targeting activity makes it useful for examining rpoB mutations, transcriptional stress responses, and cross-resistance within the rifamycin class.
Key Features and Advantages
-
RNA Polymerase Targeting: Directly inhibits bacterial DNA-dependent RNA polymerase, suppressing transcription.
-
Selective Activity Against Gram-positive Bacteria: Particularly active against many Gram-positive organisms, supporting targeted suppression strategies.
-
Core Rifamycin Compound: Serves as a foundational rifamycin structure, useful for comparative studies with other rifamycin derivatives.
-
Improved Solubility as Sodium Salt: The sodium salt form enhances dissolution in aqueous media relative to non-salt forms.
-
Tool for rpoB Mutation Studies: Frequently used to investigate mutations in the RNA polymerase beta subunit associated with rifamycin resistance.
Common Applications and Usage Notes
-
Selection of Rifamycin-Resistant Mutants: Applied in agar-based selection to isolate strains carrying rpoB mutations.
-
Transcriptional Inhibition Studies: Used to examine global transcriptional shutdown and compensatory gene expression responses.
-
Comparative Rifamycin Analysis: Supports evaluation of cross-resistance patterns between rifamycin SV and related compounds such as rifampin.
-
Antimicrobial Susceptibility Testing: Included in assays evaluating rifamycin sensitivity profiles in susceptible organisms.
-
Selective Suppression in Culture: Incorporated into media to inhibit susceptible Gram-positive bacteria when maintaining resistant strains.
Practical Tips
-
Color Contribution to Media: Rifamycin SV has a characteristic red-orange coloration that may visibly tint agar or broth. This is inherent to the compound and not an indication of degradation.
-
Spontaneous Resistance Frequency: Resistance can arise from single point mutations in rpoB. When isolating resistant colonies, confirm genetic changes to distinguish true mutants from background growth.
-
Cross-Resistance Consideration: Mutations conferring resistance to one rifamycin often affect susceptibility to others. Interpret comparative results within the context of shared RNA polymerase targeting.
-
Storage/Handling: Upon receipt, store this product desiccated under inert gas at room temperature.
